Meridian Clinical Trials Paul-TanPiengco

Maria Maccecchini is founder, President & CEO of Annovis Bio, Inc.. a company that develops treatments for Alzheimer’s (AD), Parkinson’s (PD) and other neurodegenerative diseases by normalizing axonal transport and restoring homeostasis in the brain. After selling her first company Dr. Maccecchini joined two angel group funds –
Robin Hood Ventures and Mid-Atlantic Angel Group. She mainly invests in the life science sector. She serves on several boards of biotechnology companies, organizations that promote entrepreneurship, international trade, women, charitable and not for profit organizations.